Alps Advisors Inc Oyster Point Pharma, Inc. Transaction History

Alps Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.6 - $11.2 $98,517 - $306,499	-27,366 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $24,967 - $51,361	-2,910 Reduced 9.61%	27,366 $319,000
Q4 2021 Feb 09, 2022	BUY	$10.17 - $18.96 $307,906 - $574,032	30,276 New	30,276 $553,000
Q4 2020 Feb 03, 2021	SELL	$18.13 - $25.18 $595,425 - $826,961	-32,842 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$17.83 - $29.12 $25,354 - $41,408	-1,422 Reduced 4.15%	32,842 $693,000
Q2 2020 Aug 05, 2020	SELL	$27.86 - $35.93 $127,264 - $164,128	-4,568 Reduced 11.76%	34,264 $990,000
Q1 2020 May 06, 2020	SELL	$23.65 - $40.96 $107,229 - $185,712	-4,534 Reduced 10.46%	38,832 $1.36 Million
Q4 2019 Feb 07, 2020	BUY	$13.55 - $26.15 $587,609 - $1.13 Million	43,366 New	43,366 $1.06 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.